Sildigra Softgel — Research Summary
Sildigra Softgel 100mg is a phosphodiesterase type-5 (PDE-5) inhibitor research compound manufactured by Centurion Laboratories. Each softgel capsule contains 100mg of sildenafil citrate, the same active pharmaceutical ingredient found in commercially available erectile dysfunction medications. This research-grade compound enables laboratory investigation of PDE-5 enzymatic pathways and cyclic guanosine monophosphate (cGMP) signalling mechanisms. Researchers at Stroid UK Shop can examine how PDE-5 inhibition affects vascular smooth muscle relaxation and nitric oxide-dependent pathways in controlled laboratory environments.
The softgel formulation provides consistent compound delivery for analytical studies, allowing researchers to evaluate bioavailability characteristics and absorption kinetics compared to standard tablet formulations. Centurion Laboratories’ manufacturing standards ensure reliable batch-to-batch consistency for reproducible experimental outcomes.
Laboratory Research Applications
Scientists investigate sildenafil citrate compounds across multiple research domains including cardiovascular physiology, pulmonary hypertension models, and smooth muscle function studies. The compound’s mechanism involves selective inhibition of PDE-5 enzymes, preventing cGMP degradation and maintaining vasodilation responses in tissue samples. Researchers studying sildenafil research compounds can analyse dose-response relationships, pharmacokinetic profiles, and tissue-specific PDE-5 expression patterns.
Laboratory applications include examining endothelial function, investigating nitric oxide signalling pathways, and evaluating vascular reactivity in controlled experimental conditions. Comparative studies often analyse sildenafil alongside other PDE inhibitors to understand selectivity profiles and enzymatic binding affinities. Additionally, researchers may examine interactions with selective androgen receptor modulators or peptide compounds in combined research protocols investigating hormonal and vascular system interactions.
Product Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Dosage per Softgel | 100mg |
| Manufacturer | Centurion Laboratories |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Laboratory standard |
Research Compliance Statement
Sildigra Softgel 100mg is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This compound is not intended for human consumption, clinical use, or therapeutic applications. Researchers must maintain appropriate laboratory safety protocols and ensure compliance with institutional research guidelines. All studies should be conducted in controlled laboratory environments by qualified personnel familiar with PDE-5 inhibitor handling procedures and safety requirements.
